Search Results

FDA identifies dozens of inaccurate coronavirus antibody tests

June 01, 2020 -

A total of 27 vendors will no longer be allowed to sell their antibody tests because they haven’t been shown to work. Yesterday, the FDA published a list of the makers whose tests will no longer be marketed or distributed; it’s not known whether they will be facing additional penalties. Many of them appear to be from Chinese companies.

In tests carried out by ABC News and the Mayo Clinic, half of the antibody tests examined were found to be unreliable, ...

AstraZeneca’s experimental “antibody cocktail” fails to prevent coronavirus symptoms

June 21, 2021 -

The trial, named "Storm Chaser," was on Phase III. It involved 1,121 adult volunteers from the United States and the United Kingdom. The vast majority of the volunteers did not have COVID-19 symptoms at the start of the trial. But they were exposed to the coronavirus soon after the trial started.

AstraZeneca claimed the goal of the trial was to figure out whether the long-acting antibody cocktail it developed could protect people who had recently been in contact ...

AstraZeneca begins advanced trials for COVID-19 antibody medication

October 26, 2020 -

The two initial trials for the antibody-drug will assess its ability to prevent infections for as much as a year in some patients. The trials will also explore the drug's use as a preemptive treatment for patients exposed to SARS-CoV-2. Long-acting antibodies such as the ones used in AstraZeneca’s drug mimic the ones found in the human body; these have the potential to halt the effects of COVID-19 in infected patients. AZD7442 could also be used to complement a vaccine ...

FDA panel unanimously supports new RSV antibody drug for infants

June 14, 2023 -

All 21 members of the FDA's Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted in favor of the monoclonal antibody nirsevimab on June 8. The committee agreed that the benefits of nirsevimab exceed the dangers in preventing RSV infections for newborns and infants in their initial RSV season. With the AMDAC's decision, nirsevimab is closer to receiving final regulatory approval.

In a separate 19-2 vote, the AMDAC supported the monoclonal antibody's ...

FDA criticized for restricting the use of COVID antibody treatments

January 27, 2022 - antibody treatments. While the FDA noted that the drugs are currently not cleared for use in any of the U.S. states or territories, they may be authorized in other regions if proven to work against new variants.

Doctors also have alternate therapies to battle COVID-19 cases, including new antiviral pills from Merck and Pfizer. However, they are currently still in short supply. Another antibody drug from GlaxoSmithKline that is effective against COVID ...

Eli Lilly monoclonal antibody drug trial paused over safety concerns

October 20, 2020 - antibody therapy on hundreds of people hospitalized with COVID-19. The study participants also received remdesivir, another experimental drug commonly used to treat COVID-19 patients.

However, experts have stated that pauses are not unusual in large clinical trials, mentioning that declines in the health of the volunteers are not necessarily the result of the drug being tested. Rather, these halts are meant to allow independent scientific experts to review the data ...

This Ayurvedic herb can regulate immune function and stimulate antibody production

April 20, 2021 - antibody-producing cells in the spleen, delayed type hypersensitivity (DTH), nitric oxide (NO) production, TNF-? and IL-10 production by LPS-stimulated macrophages and splenocyte (white blood cells in the spleen) proliferation.

For their in vivo experiment, the researchers treated mice with different concentrations of the extract and looked at their antibody production and immune response. They also treated macrophages and mouse splenocytes with the extract ...

Doubts raised on effectiveness of coronavirus antibody testing in the UK

July 15, 2020 -

According to a review of studies conducted by Cochrane, a U.K.-based network that assesses health research to help direct policy, roughly one in 10 antibody tests will miss cases of COVID-19. This could lead to people making harmful decisions delaying treatment or even traveling.

“There is no decision [patients] should be making based on the results of a test,” stated the review’s lead author Jon Deeks, a professor of biostatistics at Birmingham University in England....

FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment

November 12, 2020 -

The FDA extended the emergency approval to the experimental therapy known as “bamlanivimab.” It may be given to people 12 years old and older who have mild to moderate cases of the coronavirus and have not visited the emergency room or have been admitted to a hospital. Bamlanivimab is a one-time treatment that is administered through an IV.

In a statement, FDA Commissioner Stephen M. Hahn gave his support for the approval of bamlanivimab.Bamlanivimab is known ...

Medical scientists cautiously describe 100% CURE for cancer using new monoclonal antibody treatment

June 09, 2022 - antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma," the study reads.

"This treatment was to be followed by standard chemoradiotherapy and surgery."Dostarlimab works all by itself – no chemotherapy necessary

According to the Times, dostarlimab effectively "unmasks cancer cells, allowing the immune system to identify and destroy them." Further cancer treatments such as chemotherapy, ...

Covid “negative” patients are overwhelming hospitals, exactly as predicted with Antibody Dependent Enhancement

November 10, 2021 - antibody-dependent enhancement (ADE) or some other cocktail of complications caused by the injections.

"It will be interesting to look at what this is about," said Johan Björk, the head of an emergency room in Jönköping that is being overwhelmed with sick patients. "Research will certainly be done on this."

"So, if it's not covid and it seems to be an outbreak, what else has changed in, oh, say, the last 12 months?" asked one commenter at Information Liberation....

Moderna to develop booster shot after South African strain decreased its coronavirus vaccine’s antibody levels

February 10, 2021 - antibody response during a peak period. This percentage slid down to a low 16.7 percent after about two months. In some cases, antibodies against the Wuhan coronavirus became undetectable. This finding meant that any vaccine that aims to generate antibodies will eventually be rendered ineffective.

Visit Vaccines.news to find out more news about Moderna's Wuhan coronavirus jab.

Sources include:

DailyMail.co.uk

ZeroHedge.com

GreatGameIndia....

Another 14 states have been cut off from monoclonal antibody treatments, compliments of the Biden regime

April 05, 2022 -

The latest reports show that another 14 states are now prohibited from receiving shipments of sotrovimab, which is manufactured by GlaxoSmithKline (GSK) and Vir Biotechnology.

A March 30 announcement from the Department of Health and Human Services (HHS) indicated that the total number of states that are no longer receiving sotrovimab has reached 22.

The latest 14 states to get the axe include Alaska, Arizona, California, Hawaii, Idaho, Illinois, Indiana, Michigan, ...

VAXXED TO DEATH: Alarming study confirms vaxxers will face catastrophic Antibody Dependent Enhancement injuries and deaths

August 17, 2021 -

According to OurWorldInData.org, 31.7% of the world population has been vaccinated with one or more covid vaccines. That's about 2.4 billion people.

In the United States, according to the CDC, 199 million people have been vaccinated with at least one dose.

Notably, all the 2.4 billion people who took this vaccine around the world have taken an unproven, deadly, experimental medical intervention that was intentionally formulated to contain spike protein biological ...

QUACKERY: After granting EUA to covid vaccines for antibody response, FDA now says antibodies are useless

June 15, 2021 -

After earlier declaring antibody tests to be a gold standard in identifying the presence of the Chinese Virus, Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA's Center for Devices and Radiological Health, is "reminding the public" that there are severe "limitations" when it comes to Wuhan Flu antibody or serology testing.

"Antibody tests can play an important role in identifying individuals ...

Drug maker Eli Lilly strikes $375 million deal with US government for COVID-19 antibody treatment

November 02, 2020 - antibody-drug at a loss to ensure patients across the globe have access to it – even before studies showed its potential as a treatment for COVID-19.

David A. Ricks, Eli Lilly chairman and CEO, said: "The U.S. is experiencing a surge in COVID-19 cases and associated hospitalizations, and we believe bamlanivimab could be an important therapeutic option that can bring value to the overall healthcare system, as it has shown a potential benefit in clinical outcomes ...

Vaccine science is built on LIES: Antibody measurements after vaccination do not equate to comprehensive, lifelong immunity

December 15, 2025 -

The relentless focus on antibody levels as the sole measure of protection is a scientific sleight of hand, one that ignores the breathtaking complexity of the human immune system while lining the pockets of an industry built on a myth. This obsession with a single, easily measured metric has diverted our understanding of true health and left us chasing boosters for viruses that outsmart our shots before the ink on the prescription is dry. It is time to pull back the ...

CDC advisers voted on an RSV antibody using incomplete and intentionally manipulated data hiding seizure and death risks

August 25, 2025 - antibody already on the market. The data was split into two age groups:

But here’s the catch: When these two groups were combined—a standard practice in pharmacovigilance—the risk jumped to nearly four times higher, and it was statistically significant. This pooled analysis was never presented to the committee. Instead, the data was artificially divided at 38 days, the exact age when U.S. infants begin receiving routine vaccinations. By splitting the groups, ...

Infections, hospitalizations, deaths increase in Canada for the doubly and triply vaccinated, as antibody-dependent enhancement takes hold

April 12, 2022 -

FDA ignored evidence of ADE for Pfizer's covid mRNA

When the Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for Pfizer’s covid-19 mRNA, they completely ignored the risk of antibody-dependent enhancement (ADE), even though there was clear evidence that this phenomenon was occurring after vaccination [Table 5]. ADE occurs when virus-specific antibodies enhance the entry and replication of a virus in mammalian cells.

The covid-19 mRNA ...

Act of civil war? Biden regime cuts supply of life-saving monoclonal antibody in half, targeting red states

January 11, 2022 - antibody sites.”

“But for the federal government’s decision to restrict supply of monoclonal antibody treatment to Florida, my administration would have already opened additional monoclonal antibody treatment sites throughout the state,” DeSantis said in a press release.

DeSantis added that before the Biden regime “seized control of the monoclonal supply” the Sunshine State was administering 30,000 doses each week to needy, infected patients, ...